Loading...
Loading...
By Sofía Garduño - Thu, 03/14/2024 - 10:00
The week in health includes J&J acquiring Ambrx Biopharma, BD researching Peripheral Arterial Disease, and a focus on women's health.
Featured content
Thu, 04/11/2024 - 15:25
Current regulation in Mexico hinders the full development of healthcare markets, including cannabis and AI, says BPF’s Jaime Castro.
https://mexicobusiness.news/tag/johnson-johnson
More Health
By MBN Staff - Mon, 03/11/2024 - 15:32
Johnson & Johnson's acquisition of Ambrx Biopharma bolsters its commitment to precision oncology therapeutics.
By - Tue, 02/20/2024 - 10:34
When employees engage in activities, they contribute to the community and strengthen their sense of purpose and connection, writes Victor Matos.
By Guillermo Pepe - Tue, 02/20/2024 - 10:00
Artificial intelligence is an enhancer, not a savior. It is up to us to take this opportunity and make the best of it, writes Guillermo Pepe.
By Sofía Garduño - Thu, 02/08/2024 - 10:00
PAHO published a guide for managing cardiovascular risks, and J&J extended its initiative donating products for treating intestinal worms.
By MBN Staff - Thu, 02/01/2024 - 14:32
J&J to extend VERMOX Chewable donations until 2030, offering one billion doses for treating intestinal worms in vulnerable communities.
By Sofía Garduño - Thu, 01/18/2024 - 16:16
Dive into the roots of Multiple Sclerosis, WHO's plea for US$1.5 billion, and Mexico's response to rising COVID-19 cases. This is The Week in Health!
By - Mon, 01/15/2024 - 10:53
The synergy between medicine and technology has created the ability to make healthcare more accessible to everyone, writes Victor Matos.
By - Thu, 11/23/2023 - 13:22
Given the dilemma related to breast reconstruction, medical devices, especially breast implants, have emerged as silent heroes, writes Victor Matos.
By Sofía Garduño - Thu, 07/27/2023 - 10:00
This week, CONASAMA promoted self-care while PAHO highlighted the importance of primary care in achieving universal healthcare coverage.
